Erratum: Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the ARISTOTLE trial (American Heart Journal (2014) 169:1 (2530) DOI: 10.1016/j.ahj.2014.09.006)
Publication
, Journal Article
Granger, CB; Lopes, RD; Hanna, M; Ansell, J; Hylek, EM; Alexander, JH; Thomas, L; Wang, J; Bahit, MC; Verheugt, F; Lawrence, J; Xavier, D ...
Published in: American Heart Journal
April 1, 2015
Duke Scholars
Published In
American Heart Journal
DOI
EISSN
1097-6744
ISSN
0002-8703
Publication Date
April 1, 2015
Volume
169
Issue
4
Start / End Page
594
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Granger, C. B., Lopes, R. D., Hanna, M., Ansell, J., Hylek, E. M., Alexander, J. H., … Wallentin, L. (2015). Erratum: Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the ARISTOTLE trial (American Heart Journal (2014) 169:1 (2530) DOI: 10.1016/j.ahj.2014.09.006). American Heart Journal, 169(4), 594. https://doi.org/10.1016/j.ahj.2015.02.005
Granger, C. B., R. D. Lopes, M. Hanna, J. Ansell, E. M. Hylek, J. H. Alexander, L. Thomas, et al. “Erratum: Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the ARISTOTLE trial (American Heart Journal (2014) 169:1 (2530) DOI: 10.1016/j.ahj.2014.09.006).” American Heart Journal 169, no. 4 (April 1, 2015): 594. https://doi.org/10.1016/j.ahj.2015.02.005.
Granger CB, Lopes RD, Hanna M, Ansell J, Hylek EM, Alexander JH, et al. Erratum: Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the ARISTOTLE trial (American Heart Journal (2014) 169:1 (2530) DOI: 10.1016/j.ahj.2014.09.006). American Heart Journal. 2015 Apr 1;169(4):594.
Granger, C. B., et al. “Erratum: Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the ARISTOTLE trial (American Heart Journal (2014) 169:1 (2530) DOI: 10.1016/j.ahj.2014.09.006).” American Heart Journal, vol. 169, no. 4, Apr. 2015, p. 594. Scopus, doi:10.1016/j.ahj.2015.02.005.
Granger CB, Lopes RD, Hanna M, Ansell J, Hylek EM, Alexander JH, Thomas L, Wang J, Bahit MC, Verheugt F, Lawrence J, Xavier D, Wallentin L. Erratum: Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the ARISTOTLE trial (American Heart Journal (2014) 169:1 (2530) DOI: 10.1016/j.ahj.2014.09.006). American Heart Journal. 2015 Apr 1;169(4):594.
Published In
American Heart Journal
DOI
EISSN
1097-6744
ISSN
0002-8703
Publication Date
April 1, 2015
Volume
169
Issue
4
Start / End Page
594
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology